COLIN GODDARD Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for COLIN GODDARD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of COLIN GODDARD. COLIN GODDARD is Chief Executive Officer in OSI PHARMACEUTICALS INC ($OSIP) and Director in ENDOCYTE INC ($ECYT).
Latest Insider Trading Transactions of COLIN GODDARD
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 21 2018 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | D | 10.81 | 19,500 | 210,795 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | D | 2.27 | 19,500 | 44,265 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | D | 3.35 | 13,500 | 45,225 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | D | 6.02 | 13,500 | 81,270 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | D | 6.69 | 14,000 | 93,660 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | D | 10.37 | 28,000 | 290,360 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Sell | D | 24.00 | 3,300 | 79,200 | 0 | 3.3 K to 0 (-100.00 %) |
Dec 21 2018 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Sell | D | 24.00 | 7,800 | 187,200 | 0 | 7.8 K to 0 (-100.00 %) |
May 04 2018 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | A | 10.81 | 19,500 | 210,795 | 19,500 | |
May 04 2018 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Grant | A | 0.00 | 3,300 | 0 | 11,100 | 7.8 K to 11.1 K (+42.31 %) |
May 05 2017 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Grant | A | 0.00 | 3,300 | 0 | 7,800 | 4.5 K to 7.8 K (+73.33 %) |
May 06 2016 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Grant | A | 0.00 | 2,250 | 0 | 4,500 | 2.3 K to 4.5 K (+100.00 %) |
May 18 2015 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | A | 6.02 | 13,500 | 81,270 | 13,500 | |
May 18 2015 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 9.00 | 20,000 | 180,000 | 24,000 | |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 9.00 | 20,000 | 180,000 | 58,573 | 38.6 K to 58.6 K (+51.85 %) |
Jun 17 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | A | 38.01 | 46,960 | 1,784,950 | 46,960 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 9.00 | 4,000 | 36,000 | 44,000 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 50.00 | 4,000 | 200,000 | 38,573 | 42.6 K to 38.6 K (-9.40 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 9.00 | 4,000 | 36,000 | 42,573 | 38.6 K to 42.6 K (+10.37 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 9.00 | 4,000 | 36,000 | 48,000 | |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.70 | 49 | 2,680 | 38,573 | 38.6 K to 38.6 K (-0.13 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.50 | 28 | 1,526 | 38,622 | 38.7 K to 38.6 K (-0.07 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.31 | 28 | 1,521 | 38,650 | 38.7 K to 38.7 K (-0.07 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.30 | 57 | 3,095 | 38,678 | 38.7 K to 38.7 K (-0.15 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.12 | 227 | 12,285 | 38,735 | 39 K to 38.7 K (-0.58 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.11 | 27 | 1,461 | 38,962 | 39 K to 39 K (-0.07 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.10 | 1,079 | 58,374 | 38,989 | 40.1 K to 39 K (-2.69 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.05 | 188 | 10,161 | 40,068 | 40.3 K to 40.1 K (-0.47 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.02 | 31 | 1,675 | 40,256 | 40.3 K to 40.3 K (-0.08 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.01 | 85 | 4,591 | 40,287 | 40.4 K to 40.3 K (-0.21 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 54.00 | 368 | 19,872 | 40,372 | 40.7 K to 40.4 K (-0.90 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 53.94 | 212 | 11,435 | 40,740 | 41 K to 40.7 K (-0.52 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 53.91 | 28 | 1,509 | 40,952 | 41 K to 41 K (-0.07 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 53.86 | 57 | 3,070 | 40,980 | 41 K to 41 K (-0.14 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 53.84 | 566 | 30,473 | 41,037 | 41.6 K to 41 K (-1.36 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 53.83 | 617 | 33,213 | 41,603 | 42.2 K to 41.6 K (-1.46 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 53.82 | 113 | 6,082 | 42,220 | 42.3 K to 42.2 K (-0.27 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 53.81 | 27 | 1,453 | 42,333 | 42.4 K to 42.3 K (-0.06 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 53.80 | 57 | 3,067 | 42,360 | 42.4 K to 42.4 K (-0.13 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 53.76 | 156 | 8,387 | 42,417 | 42.6 K to 42.4 K (-0.37 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 9.00 | 4,000 | 36,000 | 42,573 | 38.6 K to 42.6 K (+10.37 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 9.00 | 4,000 | 36,000 | 52,000 | |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 65.16 | 1,858 | 121,067 | 38,573 | 40.4 K to 38.6 K (-4.60 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 65.15 | 536 | 34,920 | 40,431 | 41 K to 40.4 K (-1.31 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 65.10 | 1,070 | 69,657 | 40,967 | 42 K to 41 K (-2.55 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 65.00 | 536 | 34,840 | 42,037 | 42.6 K to 42 K (-1.26 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 9.00 | 4,000 | 36,000 | 42,573 | 38.6 K to 42.6 K (+10.37 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 9.00 | 4,000 | 36,000 | 56,000 | |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 74.60 | 20 | 1,492 | 38,573 | 38.6 K to 38.6 K (-0.05 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 74.50 | 100 | 7,450 | 38,593 | 38.7 K to 38.6 K (-0.26 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 74.47 | 1,313 | 97,779 | 38,693 | 40 K to 38.7 K (-3.28 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 74.43 | 10 | 744 | 40,006 | 40 K to 40 K (-0.02 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 74.42 | 70 | 5,209 | 40,016 | 40.1 K to 40 K (-0.17 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 74.41 | 50 | 3,721 | 40,086 | 40.1 K to 40.1 K (-0.12 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 74.40 | 60 | 4,464 | 40,136 | 40.2 K to 40.1 K (-0.15 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 74.17 | 10 | 742 | 40,196 | 40.2 K to 40.2 K (-0.02 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 74.10 | 20 | 1,482 | 40,206 | 40.2 K to 40.2 K (-0.05 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 74.05 | 80 | 5,924 | 40,226 | 40.3 K to 40.2 K (-0.20 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 73.95 | 251 | 18,561 | 40,306 | 40.6 K to 40.3 K (-0.62 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 73.65 | 501 | 36,899 | 40,557 | 41.1 K to 40.6 K (-1.22 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 73.62 | 10 | 736 | 41,058 | 41.1 K to 41.1 K (-0.02 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 73.60 | 30 | 2,208 | 41,068 | 41.1 K to 41.1 K (-0.07 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 73.53 | 1,024 | 75,295 | 41,098 | 42.1 K to 41.1 K (-2.43 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 73.52 | 451 | 33,158 | 42,122 | 42.6 K to 42.1 K (-1.06 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 9.00 | 4,000 | 36,000 | 42,573 | 38.6 K to 42.6 K (+10.37 %) |
Dec 10 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Grant | A | 45.72 | 4,374 | 199,979 | 38,573 | 34.2 K to 38.6 K (+12.79 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 6.88 | 8,300 | 57,063 | 41,000 | |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.74 | 47 | 2,291 | 34,199 | 34.2 K to 34.2 K (-0.14 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.66 | 235 | 11,435 | 34,246 | 34.5 K to 34.2 K (-0.68 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.65 | 845 | 41,109 | 34,481 | 35.3 K to 34.5 K (-2.39 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.64 | 46 | 2,237 | 35,326 | 35.4 K to 35.3 K (-0.13 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.60 | 46 | 2,236 | 35,372 | 35.4 K to 35.4 K (-0.13 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.58 | 470 | 22,833 | 35,418 | 35.9 K to 35.4 K (-1.31 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.57 | 847 | 41,139 | 35,888 | 36.7 K to 35.9 K (-2.31 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.50 | 1,033 | 50,101 | 36,735 | 37.8 K to 36.7 K (-2.74 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.45 | 47 | 2,277 | 37,768 | 37.8 K to 37.8 K (-0.12 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.41 | 94 | 4,551 | 37,815 | 37.9 K to 37.8 K (-0.25 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.40 | 423 | 20,473 | 37,909 | 38.3 K to 37.9 K (-1.10 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.37 | 797 | 38,551 | 38,332 | 39.1 K to 38.3 K (-2.04 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.29 | 365 | 17,626 | 39,129 | 39.5 K to 39.1 K (-0.92 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.03 | 94 | 4,515 | 39,494 | 39.6 K to 39.5 K (-0.24 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.02 | 423 | 20,312 | 39,588 | 40 K to 39.6 K (-1.06 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.01 | 563 | 27,030 | 40,011 | 40.6 K to 40 K (-1.39 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 48.00 | 422 | 20,256 | 40,574 | 41 K to 40.6 K (-1.03 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 47.99 | 235 | 11,278 | 40,996 | 41.2 K to 41 K (-0.57 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 47.98 | 423 | 20,296 | 41,231 | 41.7 K to 41.2 K (-1.02 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 47.97 | 704 | 33,771 | 41,654 | 42.4 K to 41.7 K (-1.66 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 47.95 | 141 | 6,761 | 42,358 | 42.5 K to 42.4 K (-0.33 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 6.88 | 8,300 | 57,063 | 42,499 | 34.2 K to 42.5 K (+24.27 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 6.88 | 700 | 4,813 | 49,300 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 5.25 | 7,650 | 40,163 | 0 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.83 | 520 | 33,712 | 34,199 | 34.7 K to 34.2 K (-1.50 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.60 | 548 | 35,401 | 34,719 | 35.3 K to 34.7 K (-1.55 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.54 | 57 | 3,679 | 35,267 | 35.3 K to 35.3 K (-0.16 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.53 | 57 | 3,678 | 35,324 | 35.4 K to 35.3 K (-0.16 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.52 | 231 | 14,904 | 35,381 | 35.6 K to 35.4 K (-0.65 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.49 | 144 | 9,287 | 35,612 | 35.8 K to 35.6 K (-0.40 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.40 | 115 | 7,406 | 35,756 | 35.9 K to 35.8 K (-0.32 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.32 | 87 | 5,596 | 35,871 | 36 K to 35.9 K (-0.24 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.31 | 58 | 3,730 | 35,958 | 36 K to 36 K (-0.16 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.30 | 2,193 | 141,010 | 36,016 | 38.2 K to 36 K (-5.74 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.25 | 3,619 | 232,521 | 38,209 | 41.8 K to 38.2 K (-8.65 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.21 | 144 | 9,246 | 41,828 | 42 K to 41.8 K (-0.34 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.20 | 577 | 37,043 | 41,972 | 42.5 K to 42 K (-1.36 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 6.88 | 700 | 4,813 | 42,549 | 41.8 K to 42.5 K (+1.67 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 5.25 | 7,650 | 40,163 | 41,849 | 34.2 K to 41.8 K (+22.37 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 5.25 | 8,350 | 43,838 | 7,650 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.83 | 337 | 20,837 | 34,199 | 34.5 K to 34.2 K (-0.98 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.75 | 75 | 4,631 | 34,536 | 34.6 K to 34.5 K (-0.22 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.60 | 598 | 36,837 | 34,611 | 35.2 K to 34.6 K (-1.70 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.55 | 299 | 18,403 | 35,209 | 35.5 K to 35.2 K (-0.84 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.30 | 150 | 9,195 | 35,508 | 35.7 K to 35.5 K (-0.42 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.25 | 37 | 2,266 | 35,658 | 35.7 K to 35.7 K (-0.10 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.19 | 37 | 2,264 | 35,695 | 35.7 K to 35.7 K (-0.10 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.18 | 150 | 9,177 | 35,732 | 35.9 K to 35.7 K (-0.42 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.11 | 37 | 2,261 | 35,882 | 35.9 K to 35.9 K (-0.10 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.10 | 971 | 59,328 | 35,919 | 36.9 K to 35.9 K (-2.63 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.09 | 112 | 6,842 | 36,890 | 37 K to 36.9 K (-0.30 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.07 | 150 | 9,161 | 37,002 | 37.2 K to 37 K (-0.40 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.05 | 112 | 6,838 | 37,152 | 37.3 K to 37.2 K (-0.30 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.00 | 872 | 53,192 | 37,264 | 38.1 K to 37.3 K (-2.29 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.96 | 3,739 | 227,929 | 38,136 | 41.9 K to 38.1 K (-8.93 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.83 | 38 | 2,312 | 41,875 | 41.9 K to 41.9 K (-0.09 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.81 | 75 | 4,561 | 41,913 | 42 K to 41.9 K (-0.18 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.80 | 187 | 11,370 | 41,988 | 42.2 K to 42 K (-0.44 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.78 | 37 | 2,249 | 42,175 | 42.2 K to 42.2 K (-0.09 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.77 | 75 | 4,558 | 42,212 | 42.3 K to 42.2 K (-0.18 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.76 | 106 | 6,441 | 42,287 | 42.4 K to 42.3 K (-0.25 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.75 | 156 | 9,477 | 42,393 | 42.5 K to 42.4 K (-0.37 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 5.25 | 8,350 | 43,838 | 42,549 | 34.2 K to 42.5 K (+24.42 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 5.25 | 6,650 | 34,913 | 16,000 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.45 | 555 | 32,995 | 34,199 | 34.8 K to 34.2 K (-1.60 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.40 | 494 | 29,344 | 34,754 | 35.2 K to 34.8 K (-1.40 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.18 | 895 | 52,966 | 35,248 | 36.1 K to 35.2 K (-2.48 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.16 | 308 | 18,221 | 36,143 | 36.5 K to 36.1 K (-0.84 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.12 | 2,498 | 147,682 | 36,451 | 38.9 K to 36.5 K (-6.41 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.02 | 771 | 45,504 | 38,949 | 39.7 K to 38.9 K (-1.94 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.01 | 31 | 1,829 | 39,720 | 39.8 K to 39.7 K (-0.08 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 59.00 | 913 | 53,867 | 39,751 | 40.7 K to 39.8 K (-2.25 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 58.99 | 62 | 3,657 | 40,664 | 40.7 K to 40.7 K (-0.15 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 58.98 | 123 | 7,255 | 40,726 | 40.8 K to 40.7 K (-0.30 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 5.25 | 6,650 | 34,913 | 40,849 | 34.2 K to 40.8 K (+19.45 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 5.25 | 6,675 | 35,044 | 22,650 | |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 58.61 | 577 | 33,818 | 34,199 | 34.8 K to 34.2 K (-1.66 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 58.52 | 87 | 5,091 | 34,776 | 34.9 K to 34.8 K (-0.25 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 58.50 | 663 | 38,786 | 34,863 | 35.5 K to 34.9 K (-1.87 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 58.33 | 1,625 | 94,786 | 35,526 | 37.2 K to 35.5 K (-4.37 %) |